FDA Inspection
Wake Forest Baptist Health- Blood Bank HospitalWake Forest Baptist Health- Blood Bank Hospital – FDA Inspection, Dec 14, 2017
Record Details
This FDA Inspection record concerns Wake Forest Baptist Health- Blood Bank Hospital, with an inspection on December 14, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- December 14, 2017
- Product Type
- Biologics
View Company Profile
ID · a4970092-8df2-4da0-8190-9c034ec2093a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1036762
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Wake Forest Baptist Health- Blood Bank Hospital
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 11, 2024 | Not classified | Atlanta District Office | |
| March 11, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 20, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 17, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 14, 2012 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Wake Forest Baptist Health- Blood Bank Hospital
- FDA Inspection 1249368 - 2024-09-11
- FDA Inspection 1164773 - 2022-03-11
- FDA Inspection 966437 - 2016-04-20
- FDA Inspection 887836 - 2014-07-17
- FDA Inspection 787067 - 2012-06-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.